SPIROHEPTANYL HYDANTOINS AS ROCK INHIBITORS

The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising th...

Full description

Saved in:
Bibliographic Details
Main Authors Shaw, Scott A, Vokits, Benjamin P
Format Patent
LanguageEnglish
Published 27.05.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
AbstractList The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables are as defined herein. These compounds are selective ROCK inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating cardiovascular, smooth muscle, oncologic, neuropathologic, autoimmune, fibrotic, and/or inflammatory disorders using the same.
Author Shaw, Scott A
Vokits, Benjamin P
Author_xml – fullname: Shaw, Scott A
– fullname: Vokits, Benjamin P
BookMark eNrjYmDJy89L5WTQDg7wDPL3cA0IcfSL9FHwiHRx9Avx9_QLVnAMVgjyd_ZW8PTz8HTyDPEPCuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGRoaGpqZmhhaOhsbEqQIAKfkn8w
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2021155618A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2021155618A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:12:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2021155618A13
Notes Application Number: US201816629784
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210527&DB=EPODOC&CC=US&NR=2021155618A1
ParticipantIDs epo_espacenet_US2021155618A1
PublicationCentury 2000
PublicationDate 20210527
PublicationDateYYYYMMDD 2021-05-27
PublicationDate_xml – month: 05
  year: 2021
  text: 20210527
  day: 27
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies BRISTOL-MYERS SQUIBB COMPANY
RelatedCompanies_xml – name: BRISTOL-MYERS SQUIBB COMPANY
Score 3.3317218
Snippet The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, wherein all the variables...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title SPIROHEPTANYL HYDANTOINS AS ROCK INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210527&DB=EPODOC&locale=&CC=US&NR=2021155618A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KFfVNq-JRJaDkRYJJmvMhSE4StUnIIe1T6SYpCFKLjfj3nV1S7VPfdndg9oA5vt2dGYD7Rifohi5EoTZqXVBIRfXgvBIUTSNzqRqRiqVrGsdaWCrPE3XSg49NLAzLE_rDkiOiRFUo7y3T16v_SyyP_a1cP5J3HPp8CgrL4zt0jPhFlXXecyw_TbzE5V3XKnM-zhhNoqUgDRux0h460jqVB__NoXEpq22jEhzDfor8lu0J9JrlAA7dTe21ARyMuydvbHbStz6FhzyNsiT008KOp69cOPXsuEgQfnN2zmWJ-8JFcRg5UZFk-RncBX7hhgLOOvvb5KzMt5c4Ooc-wv_mAjhTIaRuJFNtFJOWh0Z8ZZgLQ1QrjchibVzCcBenq93kaziiXfoeLutD6Ldf380NmtmW3LLT-QXAhHvH
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB5KFeubVsWjakDJiwR75HwIkpPE5iJJpX0K3SQFQWqxEf--s0urferbsgOzB8zx7ezMADzWCkE3dNEXKrVSBJGUVA_OS0GUZTIflCNSsnJNYSR7E_F1Kk1b8LHNhWF1Qn9YcUSUqBLlvWH6evX_iGWzv5XrZ_KOU58vbq7b_AYdI36Rhgpvm7qTxHZs8ZalTzI-ShltQFtBqgZipQN0shUqD86bSfNSVrtGxT2BwwT5LZtTaNXLLnSsbe-1LhyFm5A3DjfStz6Dpyzx09hzktyIZgHnzWwjymOE35yRcWlsjTk_8nzTz-M0O4cH18ktT8BVi79DFpNsd4ujC2gj_K8vgdNEQqp6oEm1qNH20IivVG2h9qVSJsN-pV5Bbx-n6_3ke-h4eRgUgR-Nb-CYkmhsfKj0oN18fde3aHIbcsdu6he5qn66
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SPIROHEPTANYL+HYDANTOINS+AS+ROCK+INHIBITORS&rft.inventor=Shaw%2C+Scott+A&rft.inventor=Vokits%2C+Benjamin+P&rft.date=2021-05-27&rft.externalDBID=A1&rft.externalDocID=US2021155618A1